|Bid||106.18 x 1100|
|Ask||106.13 x 800|
|Day's Range||105.64 - 108.40|
|52 Week Range||61.61 - 115.14|
|Beta (5Y Monthly)||0.89|
|PE Ratio (TTM)||56.25|
|Earnings Date||Jan 20, 2021 - Jan 25, 2021|
|Forward Dividend & Yield||1.44 (1.34%)|
|Ex-Dividend Date||Oct 14, 2020|
|1y Target Est||119.94|
Wells Faro, Pfizer and AbbVie all enjoy the confidence of several gurus
If you want to know who really controls Abbott Laboratories (NYSE:ABT), then you'll have to look at the makeup of its...
There have also been key advances in COVID-19 testing and another Food and Drug Administration (FDA) emergency-use authorization (EUA) for a COVID-19 therapy. The company currently sells six COVID-19 tests that have received FDA EUA. Abbott reported third-quarter sales related to its COVID-19 testing products and services totaling $881 million.